Cardlytics
CDLX
121 hedge funds and large institutions have $172M invested in Cardlytics in 2022 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 43 increasing their positions, 39 reducing their positions, and 30 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 39
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
0.63% less ownership
Funds ownership: 9.61% → 8.98% (-0.63%)
8% less funds holding
Funds holding: 132 → 121 (-11)
30% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 30
42% less capital invested
Capital invested by funds: $297M → $172M (-$125M)
46% less call options, than puts
Call options by funds: $1.83M | Put options by funds: $3.37M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$6.55M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.57M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$2.08M |
| 4 |
Morgan Stanley
New York
|
+$1.56M |
| 5 |
GEH
General Equity Holdings
Brooklyn,
New York
|
+$1.46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$19.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.83M |
| 3 |
ACM
Alua Capital Management
New York
|
-$3.44M |
| 4 |
JCM
JS Capital Management
New York
|
-$3.37M |
| 5 |
AA
Antipodean Advisors
New York
|
-$2.87M |
CDLX Hedge Fund Activity: Q4 2022 in Review
121 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q4 2022, worth a combined $172M — down 42% from $297M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of CDLX and 21 opened new positions — a net loss of 9 holders — while 39 trimmed existing stakes and 43 added.
The largest buyer was D.E. Shaw & Co, adding an estimated $6.55M. The largest seller was Wellington Management Group, exiting entirely with an estimated $19.9M sold.
- 121 institutional investors held Cardlytics (CDLX) as of Q4 2022, down from 132 in Q3 2022.
- Funds reported $172M of Cardlytics stock for Q4 2022, down 42% quarter-over-quarter.
- 21 funds opened new Cardlytics positions in Q4 2022 and 30 closed out, a net change of -9 holders.
- The largest Cardlytics buyer in Q4 2022 was D.E. Shaw & Co, an estimated $6.55M added.
- The largest Cardlytics seller in Q4 2022 was Wellington Management Group, an estimated $19.9M sold.
Based on aggregated 13F filings for Q4 2022.